The World Bank recently approved $15.5 million in support of the Sierra Leone government’s Health Sector Recovery Plan under the Health Service Delivery and System Support Project.
It will be implemented over a three-year period and co-financed by a $10 million International Development Association credit facility and $5.5 million from the Ebola Recovery and Reconstruction Trust Fund.
“The project will help address the immediate aftermath of the Ebola epidemic, strengthen the health system and improve health outcomes which are currently worse than in countries with comparable socio-economic characteristics and health spending,” Henry Kerali, World Bank Country Director for Sierra Leone said.
The funding will strengthen the resilience and capacity in case of future emergencies in the country that comes last in global rankings because of limited physical and financial access to healthcare services and limited health human resources.
South Sudan will receive $40 million additional financing towards the restoration of its collapsed healthcare system after decades of conflict, massive displacement of the population and widespread insecurity.
The World Bank has invested more than $63 million in the Health Rapid Result Project (HRRP); an initial $28 million in 2012 and $35 million in 2014, enabling millions of residents of Jonglei and Upper Nile to receive vital healthcare services.
South Sudan has among the lowest worldwide health indicators.
Since its launch, the HRRP has contributed to an increase in the number of children under the age of 12 months immunized against DPT3; pregnant women receiving antenatal care during a visit to a health provider; and deliveries attended by skilled health personnel.
Purchasing and distribution of long-lasting insecticide-treated malaria nets has risen from zero to more than two million.
This additional funds will go towards improving the delivery of high impact primary healthcare services; strengthening the coordination, monitoring and evaluation capacities of South Sudan’s Health Ministry; and procurement and distribution of pharmaceuticals.